Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 18, 2025

SAN MATEO, Calif., and CAMBRIDGE, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a biopharmaceutical company, today reported fourth quarter and full year 2024 financial results.